BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24099844)

  • 1. Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
    Eshaghi A; Bodini B; Ridgway GR; García-Lorenzo D; Tozer DJ; Sahraian MA; Thompson AJ; Ciccarelli O
    Neuroimage; 2014 Feb; 86():257-64. PubMed ID: 24099844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
    Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
    Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
    Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of regional grey matter atrophy in multiple sclerosis.
    Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
    Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.
    Bodini B; Khaleeli Z; Cercignani M; Miller DH; Thompson AJ; Ciccarelli O
    Hum Brain Mapp; 2009 Sep; 30(9):2852-61. PubMed ID: 19172648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.
    Khaleeli Z; Cercignani M; Audoin B; Ciccarelli O; Miller DH; Thompson AJ
    Neuroimage; 2007 Aug; 37(1):253-61. PubMed ID: 17566765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.
    Sepulcre J; Sastre-Garriga J; Cercignani M; Ingle GT; Miller DH; Thompson AJ
    Arch Neurol; 2006 Aug; 63(8):1175-80. PubMed ID: 16908748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA; Lee JC; Nakamura K; Fisher E
    J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
    Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
    Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
    Sastre-Garriga J; Ingle GT; Chard DT; Cercignani M; Ramió-Torrentà L; Miller DH; Thompson AJ
    Brain; 2005 Jun; 128(Pt 6):1454-60. PubMed ID: 15817511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.
    Khaleeli Z; Sastre-Garriga J; Ciccarelli O; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1076-82. PubMed ID: 17287235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.
    Ceccarelli A; Rocca MA; Valsasina P; Rodegher M; Pagani E; Falini A; Comi G; Filippi M
    Hum Brain Mapp; 2009 Sep; 30(9):3009-19. PubMed ID: 19172642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
    van de Pavert SH; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ridgway GR; Geurts JJ; Ron M; Yousry TA; Thompson AJ; Miller DH; Chard DT; Ciccarelli O
    J Neurol Neurosurg Psychiatry; 2016 May; 87(5):461-7. PubMed ID: 25926483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.
    Ceccarelli A; Rocca MA; Pagani E; Colombo B; Martinelli V; Comi G; Filippi M
    Neuroimage; 2008 Aug; 42(1):315-22. PubMed ID: 18501636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis.
    Rothstein TL
    Front Neurol; 2020; 11():581537. PubMed ID: 33281717
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.
    De Vita E; Ridgway GR; White MJ; Porter MC; Caine D; Rudge P; Collinge J; Yousry TA; Jager HR; Mead S; Thornton JS; Hyare H
    Neuroimage Clin; 2017; 13():89-96. PubMed ID: 27942451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.